The semi-permanent goal is to develop a secure and effective immunogen that protects people worldwide from getting infected with HIV. However, even if associate degree immunogen only protects several people who get vaccinated, or even if it provides however total protection by reducing the prospect of infection, it will still have a big impact on the rates of transmission and facilitate management of the pandemic, considerably for populations at high risk of HIV infection. A partially effective immunogen would possibly decrease the amount of people administrative body get infected with HIV and reducing the amount of people administrative body can pass the virus on to others. By significantly reducing the number of recent infections, we are going to stop the epidemic.
- Track 1-1 Clinical Trials for HIV-vaccine development
- Track 2-2 Possible solutions regarding HIV-Vaccine
- Track 3-3 Available vaccine-based treatments for HIV
- Track 4-4 Various struggles regarding vaccine development
- Track 5-5 Vaccination treatment for HIV